Keywords: cephalon, plans, file, treanda, nda, 3rd, qtr

Cephalon plans to file Treanda NDA in 3rd qtr

Article | 09 July 2007

Print This

US biopharmaceutical firm Cephalon says that, based on positive results from a European Phase III study, it plans to file ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in